previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | next
| CSGID ID | Priority | Locus Tag | NCBI GI | Gene Name |
Common Name | Sequence Length |
Comment | Project | Homolog PDB ID |
Homolog Sequence Identity |
Target Organism | TIGR Main Role | TIGR Subrole | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IDP00579 | 1 | YPO1122 | 16121422 | tolR | colicin uptake protein TolR | 142 | Conserved Gene / Pathway | March 2008 | 2JWK | 23.9% | Yersinia pestis | Cellular processes | Toxin production and resistance | |||||||||||||||||
| IDP00580 | 1 | YPO0059 | 16120412 | kbl | 2-amino-3-ketobutyrate coenzyme A ligase... | 403 | Conserved Gene / Pathway | March 2008 | 1BS0 | 82.9% | Yersinia pestis | Biosynthesis of cofactors, prosthetic groups, and carriers | Biotin | |||||||||||||||||
| IDP00581 | 1 | YPO3070 | 16123247 | putative arsenate reductase | 118 | Virulence Associated Factor | March 2008 | 1I9D | 45.8% | Yersinia pestis | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP00582 | 1 | YPO2528 | 16122747 | menF | menaquinone-specific isochorismate synth... | 455 | Conserved Gene / Pathway | March 2008 | 1I1Q | 51.2% | Yersinia pestis | Biosynthesis of cofactors, prosthetic groups, and carriers | Menaquinone and ubiquinone | |||||||||||||||||
| IDP00583 | 1 | YPO2752 | 16122956 | mepA | penicillin-insensitive murein endopeptid... | 275 | Drug Target Function | March 2008 | 1TZP | 67.6% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00584 | 1 | YPO0117 | 16120462 | metF | 5,10-methylenetetrahydrofolate reductase... | 294 | Virulence Associated Factor | March 2008 | 1B5T | 86.4% | Yersinia pestis | Amino acid biosynthesis | Aspartate family | |||||||||||||||||
| IDP00585 | 1 | YPO0116 | 16120461 | metL | bifunctional aspartate kinase II/homoser... | 811 | Virulence Associated Factor | March 2008 | 1EBF | 15.5% | Yersinia pestis | Amino acid biosynthesis | Aspartate family | |||||||||||||||||
| IDP00586 | 1 | YPO3789 | 16123923 | metR | lysR-family transcriptional regulatory p... | 317 | Virulence Associated Factor | March 2008 | 1AL3 | 23.7% | Yersinia pestis | Amino acid biosynthesis | Aspartate family | |||||||||||||||||
| IDP00587 | 1 | YPO1507 | 16121780 | mglB | galactose-binding protein | 335 | Virulence Associated Factor | March 2008 | 1ABE | 80.9% | Yersinia pestis | Transport and binding proteins | Carbohydrates, organic alcohols, and acids | |||||||||||||||||
| IDP00588 | 1 | YPO2077 | 16122316 | minD | cell division inhibitor MinD | 270 | Conserved Gene / Pathway | March 2008 | 1G3Q | 32.6% | Yersinia pestis | Cellular processes | Cell division | |||||||||||||||||
| IDP00589 | 1 | YPO0954 | 161486886 | mltC | membrane-bound lytic murein transglycosy... | 358 | Drug Target Function | March 2008 | 1QSA | 17.6% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00590 | 1 | YPO1078 | 16121379 | mltD | predicted membrane-bound lytic murein tr... | 475 | Drug Target Function | March 2008 | 1E0G | 7.8% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00591 | 1 | YPO0145 | 161486893 | mrcA | penicillin-binding protein | 859 | Drug Target Function | March 2008 | 2C5W | 21% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00592 | 1 | YPO3393 | 16123542 | mrcB | penicillin-binding protein 1b | 824 | Virulence Associated Factor | March 2008 | 2BG1 | 19.3% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00593 | 1 | YPO1232 | 16121518 | msgA | putative stress response protein | 80 | Conserved Gene / Pathway | March 2008 | 1GHH | 31.3% | Yersinia pestis | Cellular processes | Pathogenesis | |||||||||||||||||
| IDP00594 | 1 | YPO3569 | 16123713 | murA | UDP-N-acetylglucosamine 1-carboxyvinyltr... | 420 | Conserved Gene / Pathway | March 2008 | 1A2N | 91.7% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00595 | 1 | YPO3760 | 16123897 | murB | UDP-N-acetylenolpyruvoylglucosamine redu... | 345 | Drug Target Function | March 2008 | 1HSK | 60.9% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00596 | 1 | YPO0555 | 16120883 | murG | N-acetylglucosaminyl transferase | 356 | Drug Target Function | March 2008 | 1F0K | 78.4% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00597 | 1 | YPO3909 | 16124041 | murI | glutamate racemase | 287 | Conserved Gene / Pathway | March 2008 | 1B73 | 71.4% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00600 | 1 | SACOL0532 | 57285557 | hypothetical protein SACOL0532 | 51 | Drug Target Function | March 2008 | Staphylococcus aureus | 0 | 0 | ||||||||||||||||||||
| IDP00601 | 1 | SACOL0893 | 57284352 | pathogenicity island protein | 48 | Conserved Gene / Pathway | March 2008 | Staphylococcus aureus | Cellular processes | Pathogenesis | ||||||||||||||||||||
| IDP00602 | 1 | SACOL0903 | 57285779 | pathogenicity island protein | 72 | Conserved Gene / Pathway | March 2008 | Staphylococcus aureus | Cellular processes | Pathogenesis | ||||||||||||||||||||
| IDP00603 | 1 | SACOL0726 | 57285695 | sarX | staphylococcal accessory protein X | 141 | Conserved Gene / Pathway | March 2008 | Staphylococcus aureus | Cellular processes | Toxin production and resistance | |||||||||||||||||||
| IDP00604 | 1 | SACOL1610 | 57286132 | sodA2 | superoxide dismutase | 199 | Conserved Gene / Pathway | March 2008 | 1AP5 | 72.9% | Staphylococcus aureus | Cellular processes | Detoxification | |||||||||||||||||
| IDP00605 | 1 | SACOL1745 | 57284754 | pyk | pyruvate kinase | 585 | Drug Target Function | March 2008 | 1A3W | 60% | Staphylococcus aureus | Energy metabolism | Glycolysis/gluconeogenesis | |||||||||||||||||
| IDP00606 | 1 | SACOL1933 | 57286280 | ThiJ/PfpI family protein | 171 | Drug Target Function | March 2008 | 1G2I | 49.1% | Staphylococcus aureus | Unknown function | General | ||||||||||||||||||
| IDP00607 | 1 | SACOL2116 | 57286332 | murAB | UDP-N-acetylglucosamine 1-carboxyvinyltr... | 419 | Drug Target Function | March 2008 | 1A2N | 42% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00608 | 1 | SACOL0127 | 57285334 | phosphonate ABC transporter, ATP-binding... | 257 | Conserved Gene / Pathway | March 2008 | 1B0U | 35% | Staphylococcus aureus | Transport and binding proteins | Other | ||||||||||||||||||
| IDP00609 | 1 | SACOL0690 | 57285660 | ABC transporter, ATP-binding protein | 247 | Conserved Gene / Pathway | March 2008 | 1B0U | 29.1% | Staphylococcus aureus | Transport and binding proteins | Unknown substrate | ||||||||||||||||||
| IDP00610 | 1 | SACOL1437 | 57286088 | cold shock protein, CSD family | 66 | Conserved Gene / Pathway | March 2008 | 1C9O | 75.8% | Staphylococcus aureus | Cellular processes | Adaptations to atypical conditions | ||||||||||||||||||
| IDP00611 | 1 | SACOL1952 | 57286299 | ferritins family protein | 166 | Conserved Gene / Pathway | March 2008 | 1AEW | 39.2% | Staphylococcus aureus | Transport and binding proteins | Cations and iron carrying compounds | ||||||||||||||||||
| IDP00612 | 1 | SACOL0582 | 57285598 | nusG | transcription antitermination protein Nu... | 182 | Drug Target Function | March 2008 | 1M1G | 31.9% | Staphylococcus aureus | Transcription | Transcription factors | |||||||||||||||||
| IDP00613 | 1 | SACOL1377 | 57284532 | tkt | transketolase | 662 | Drug Target Function | March 2008 | 1AY0 | 51.2% | Staphylococcus aureus | Energy metabolism | Pentose phosphate pathway | |||||||||||||||||
| IDP00614 | 1 | SACOL2109 | 57286325 | modification methylase, HemK family | 278 | Drug Target Function | March 2008 | 1NV8 | 32% | Staphylococcus aureus | Unknown function | General | ||||||||||||||||||
| IDP00615 | 1 | SACOL1160 | 57284445 | sdhB | succinate dehydrogenase iron-sulfur subu... | 271 | Conserved Gene / Pathway | March 2008 | 1E7P | 25.1% | Staphylococcus aureus | Energy metabolism | TCA cycle | |||||||||||||||||
| IDP00616 | 1 | SACOL1586 | 57286108 | hypothetical protein SACOL1586 | 94 | Drug Target Function | March 2008 | Staphylococcus aureus | 0 | 0 | ||||||||||||||||||||
| IDP00617 | 1 | SACOL1880 | 57284800 | lukD | leukotoxin LukD | 327 | Virulence Associated Factor | March 2008 | 1LKF | 75.5% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | |||||||||||||||||
| IDP00618 | 1 | SACOL2348 | 57285082 | drug transporter, putative | 215 | Conserved Gene / Pathway | March 2008 | Staphylococcus aureus | Cellular processes | Toxin production and resistance | ||||||||||||||||||||
| IDP00619 | 1 | SACOL2464 | 57286459 | addiction module toxin, Txe/YoeB family ... | 88 | Virulence Associated Factor | March 2008 | Staphylococcus aureus | Cellular processes | Toxin production and resistance | ||||||||||||||||||||
| IDP00620 | 1 | SACOL0937 | 57285812 | dltC | D-alanine--poly(phosphoribitol) ligase s... | 78 | Conserved Gene / Pathway | March 2008 | 1DV5 | 41% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | |||||||||||||||||
| IDP00621 | 1 | SACOL2217 | 57284998 | infA | translation initiation factor IF-1 | 72 | Drug Target Function | March 2008 | 1AH9 | 68.1% | Staphylococcus aureus | Protein synthesis | Translation factors | |||||||||||||||||
| IDP00622 | 1 | SACOL1878 | 57284798 | epiA | lantibiotic epidermin precursor EpiA | 47 | Conserved Gene / Pathway | March 2008 | Staphylococcus aureus | Cellular processes | Toxin production and resistance | |||||||||||||||||||
| IDP00623 | 1 | SACOL2731 | 57285285 | cold shock protein, CSD family | 66 | Conserved Gene / Pathway | March 2008 | 1C9O | 68.2% | Staphylococcus aureus | Cellular processes | Adaptations to atypical conditions | ||||||||||||||||||
| IDP00624 | 1 | SACOL1874 | 57284795 | epiP | epidermin leader peptide processing seri... | 457 | Drug Target Function | March 2008 | Staphylococcus aureus | Cellular processes | Toxin production and resistance | |||||||||||||||||||
| IDP00625 | 1 | SACOL2404 | 57285135 | addiction module toxin, Txe/YoeB family ... | 88 | Virulence Associated Factor | March 2008 | 2A6Q | 51.1% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP00626 | 1 | SACOL2506 | 57285191 | sarT | staphylococcal accessory regulator T | 118 | Conserved Gene / Pathway | March 2008 | 1FZP | 33.1% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | |||||||||||||||||
| IDP00627 | 1 | SACOL0552 | 57285570 | hypothetical protein SACOL0552 | 133 | Conserved Gene / Pathway | March 2008 | 1E3H | 31.6% | Staphylococcus aureus | Cellular processes | Adaptations to atypical conditions | ||||||||||||||||||
| IDP00628 | 1 | SACOL0369 | 57285482 | prophage L54a, Clp protease, putative | 257 | Drug Target Function | March 2008 | 1TG6 | 22.2% | Staphylococcus aureus | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP00629 | 1 | SACOL1875 | 57284796 | epiD | epidermin biosynthesis protein EpiD | 172 | Conserved Gene / Pathway | March 2008 | 1E20 | 53.5% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | |||||||||||||||||
| IDP00630 | 1 | SACOL0861 | 57284322 | cold shock protein, CSD family | 66 | Conserved Gene / Pathway | March 2008 | 1C9O | 71.2% | Staphylococcus aureus | Cellular processes | Adaptations to atypical conditions | ||||||||||||||||||
| IDP00631 | 1 | SACOL1537 | 57284636 | scpB | segregation and condensation protein B | 180 | Conserved Gene / Pathway | March 2008 | 1T6S | 23.9% | Staphylococcus aureus | Cellular processes | Cell division | |||||||||||||||||
| IDP00632 | 1 | SACOL2295 | 57286421 | staphyloxanthin biosynthesis protein, pu... | 166 | Conserved Gene / Pathway | March 2008 | 2K3A | 68.1% | Staphylococcus aureus | Cellular processes | Pathogenesis | ||||||||||||||||||
| IDP00633 | 1 | SACOL0118 | 57286667 | sodA1 | superoxide dismutase | 199 | Conserved Gene / Pathway | March 2008 | 1AP5 | 64.8% | Staphylococcus aureus | Cellular processes | Detoxification | |||||||||||||||||
| IDP00634 | 1 | SACOL1722 | 57284733 | tig | trigger factor | 433 | Drug Target Function | March 2008 | 1HXV | 31.6% | Staphylococcus aureus | Protein fate | Protein folding and stabilization | |||||||||||||||||
| IDP00635 | 1 | SACOL2270 | 57286396 | modC | molybdenum ABC transporter, ATP-binding ... | 201 | Conserved Gene / Pathway | March 2008 | 1B0U | 38.8% | Staphylococcus aureus | Transport and binding proteins | Anions | |||||||||||||||||
| IDP00636 | 1 | SACOL1118 | 57285904 | typA | GTP-binding protein TypA | 615 | Drug Target Function | March 2008 | 1AIP | 24.4% | Staphylococcus aureus | Unknown function | General | |||||||||||||||||
| IDP00637 | 1 | SACOL1727 | 57284738 | infC | translation initiation factor IF-3 | 175 | Drug Target Function | March 2008 | 1I96 | 37.7% | Staphylococcus aureus | Protein synthesis | Translation factors | |||||||||||||||||
| IDP00638 | 1 | SACOL2736 | 57285290 | gidB | glucose-inhibited division protein B | 239 | Drug Target Function | March 2008 | 1JSX | 63.2% | Staphylococcus aureus | Unknown function | General | |||||||||||||||||
| IDP00639 | 1 | SACOL0114 | 57286663 | capsular polysaccharide biosynthesis gly... | 230 | Conserved Gene / Pathway | March 2008 | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||||
| IDP00640 | 1 | SACOL1807 | 57286241 | rhodanese-like domain protein | 103 | Drug Target Function | March 2008 | 1GN0 | 27.2% | Staphylococcus aureus | Unknown function | General | ||||||||||||||||||
| IDP00641 | 1 | SACOL1866 | 57284787 | serine protease SplD, putative | 239 | Drug Target Function | March 2008 | 1AGJ | 43.5% | Staphylococcus aureus | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP00642 | 1 | SACOL2384 | 57285116 | sarZ | staphylococcal accessory protein Z | 148 | Conserved Gene / Pathway | March 2008 | 1LNW | 35.1% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | |||||||||||||||||
| IDP00643 | 1 | SACOL2638 | 57286542 | precorrin-2 dehydrogenase | 201 | Conserved Gene / Pathway | March 2008 | 1PJQ | 27.9% | Staphylococcus aureus | Biosynthesis of cofactors, prosthetic groups, and carriers | Heme, porphyrin, and cobalamin | ||||||||||||||||||
| IDP00644 | 1 | SACOL0220 | 57286684 | flavohemoprotein, putative | 381 | Conserved Gene / Pathway | March 2008 | 1CQX | 38.8% | Staphylococcus aureus | Unknown function | General | ||||||||||||||||||
| IDP00645 | 1 | SACOL0442 | 57286815 | staphylococcal enterotoxin, putative | 203 | Virulence Associated Factor | March 2008 | 1M4V | 27.1% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP00646 | 1 | SACOL0887 | 57284346 | sei | staphylococcal enterotoxin type I | 242 | Virulence Associated Factor | March 2008 | 1AN8 | 55% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | |||||||||||||||||
| IDP00647 | 1 | SACOL1657 | 57286179 | enterotoxin type A, putative | 234 | Virulence Associated Factor | March 2008 | 1AN8 | 40.2% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | ||||||||||||||||||
| IDP00648 | 1 | SACOL2160 | 57286373 | hemolysin III, putative | 227 | Conserved Gene / Pathway | March 2008 | Staphylococcus aureus | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||||
| IDP00649 | 1 | SACOL0046 | 57286601 | metallo-beta-lactamase family protein | 442 | Drug Target Function | March 2008 | 1QH3 | 15.6% | Staphylococcus aureus | Unknown function | Enzymes of unknown specificity | ||||||||||||||||||
| IDP00650 | 1 | SACOL0113 | 57286662 | NAD-dependent epimerase/dehydratase fami... | 323 | Conserved Gene / Pathway | March 2008 | 1A9Y | 36.2% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP00651 | 1 | SACOL0143 | 57285346 | cap5H | capsular polysaccharide biosynthesis pro... | 208 | Conserved Gene / Pathway | March 2008 | 1KHR | 27.9% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | |||||||||||||||||
| IDP00652 | 1 | SACOL0151 | 57285354 | cap5P | UDP-N-acetylglucosamine 2-epimerase Cap5... | 391 | Conserved Gene / Pathway | March 2008 | 1F6D | 56% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | |||||||||||||||||
| IDP00653 | 1 | SACOL0451 | 57286824 | ahpF | alkyl hydroperoxide reductase, subunit F... | 507 | Conserved Gene / Pathway | March 2008 | 1A8L | 54.8% | Staphylococcus aureus | Cellular processes | Detoxification | |||||||||||||||||
| IDP00654 | 1 | SACOL0452 | 57286825 | ahpC | alkyl hydroperoxide reductase, C subunit... | 189 | Conserved Gene / Pathway | March 2008 | 1E2Y | 75.1% | Staphylococcus aureus | Cellular processes | Detoxification | |||||||||||||||||
| IDP00655 | 1 | SACOL0536 | 57285561 | ksgA | dimethyladenosine transferase | 297 | Conserved Gene / Pathway | March 2008 | 1QAM | 31.6% | Staphylococcus aureus | Cellular processes | Toxin production and resistance | |||||||||||||||||